Literature DB >> 27370015

Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.

Wungrak Choi1, Yong Woo Ji1,2, Hwa-Yong Ham1, Areum Yeo1, Hyemi Noh1, Su-Eon Jin3, Jong Suk Song4, Hyeon Chang Kim5, Eung Kwon Kim1,2, Hyung Keun Lee6,2.   

Abstract

We identified the characteristics of myeloid-derived suppressor cells (MDSCs) and investigated their mechanism of induction and their functional role in allograft rejection using a murine corneal allograft model. In mice, MDSCs coexpress CD11b and myeloid differentiation antigen Gr-1. Gr-1+CD11b+ cells infiltrated allografted corneas between 4 d and 4 wk after surgery; however, the frequencies of Gr-1+CD11b+ cells were not different between accepted and rejected allografts or in peripheral blood or BM. Of interest, Gr-1intCD11b+ cells, but not Gr-1hiCD11b+ cells, infiltrated the accepted graft early after surgery and expressed high levels of immunosuppressive cytokines, including IL-10, TGF-β, and TNF-related apoptosis-inducing ligand. This population remained until 4 wk after surgery. In vitro, only high dose (>100 ng/ml) of IFN-γ plus GM-CSF could induce immunosuppressive cytokine expression in Gr-1intCD11b+ cells. Furthermore, adoptive transfer of Gr-1intCD11b+ cells reduced T cell infiltration, which improved graft survival. In conclusion, high-dose IFN-γ in allograft areas is essential for development of Gr-1intCD11b+ MDSCs in corneal allografts, and subtle environmental changes in the early period of the allograft can result in a large difference in graft survival. © Society for Leukocyte Biology.

Entities:  

Keywords:  TNF-related apoptosis-inducing ligand (TRAIL); adoptive transfer; interferon-γ (IFN-γ); keratoplasty; myeloid differentiation antigen Gr-1

Mesh:

Substances:

Year:  2016        PMID: 27370015     DOI: 10.1189/jlb.5A1115-508RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

Review 1.  Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.

Authors:  Jilu Zhang; Alan Hodges; Shu-Hsia Chen; Ping-Ying Pan
Journal:  Cell Immunol       Date:  2021-02-04       Impact factor: 4.868

Review 2.  The Yin and Yang of Myeloid Derived Suppressor Cells.

Authors:  Snehil Budhwar; Priyanka Verma; Rachna Verma; Sangeeta Rai; Kiran Singh
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

Review 3.  Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation.

Authors:  Nathaniel Oberholtzer; Carl Atkinson; Satish N Nadig
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

4.  Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice.

Authors:  Jun Zhu; Takenori Inomata; Keiichi Fujimoto; Koichiro Uchida; Kenta Fujio; Ken Nagino; Maria Miura; Naoko Negishi; Yuichi Okumura; Yasutsugu Akasaki; Kunihiko Hirosawa; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Ai Yanagawa; Akie Midorikawa-Inomata; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

5.  Rapamycin Nano-Micelle Ophthalmic Solution Reduces Corneal Allograft Rejection by Potentiating Myeloid-Derived Suppressor Cells' Function.

Authors:  Chao Wei; Yuexin Wang; Li Ma; Xin Wang; Hao Chi; Sai Zhang; Ting Liu; Zhiyuan Li; Demeng Xiang; Yanling Dong; Xianggen Wu; Weiyun Shi; Hua Gao
Journal:  Front Immunol       Date:  2018-10-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.